Now, although the funding environment looks different from the pandemic-era biotech bubble, conditions are ripening for the return of the IPO as a viable exit for private drugmakers, according to a panel planned for June’s BIO International Convention in San Diego.

'After the presidency, I may go to Venezuela and run against Delcy. I may run against Delcy. They like me in Venezuela', Trump joked

The U.S. wants the benefit of hegemony under Trump. It doesn’t want the responsibilities of being the hegemon: ensuring collective security, promoting economic openness, nurturing these alliances. Trump doesn’t really want to behave like a superpower. He wants to wield superpowers.

Fired Kennedy Center boss Ric Grenell is reportedly scheming his way back into the Trump administration, but his prospective gig is vastly different from leading a premier performing arts center.